Interview with Jan Warmerdam, Director Healthcare Relations, IMS Health…
IMS Health sets itself apart because of its global reach, while mastering local expertise. Clearly, every market is…
IMS Health Netherlands
Last updated: 13.02.2014
Address: Fascinatio Boulevard 1242, 2909 VA Capelle a/d IJssel, The Netherlands
Tel: +31 (0)10 440 68 00
Web: http://www.imshealth.com/portal/site/ims?CURRENT_LOCALE=en_nd
Company description
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. We offer a variety of solutions to help clients understand the marketplace, improve marketing effectiveness and optimize sales productivity. With a presence in more than 100 countries and over 55 years of experience, IMS applies leading-edge technologies to transform billions of pharmaceutical transactions collected from thousands of sources into strategic insights. Interpreted and analyzed by IMS experts, these insights are an unmatched source of trends and perspectives about the pharmaceutical marketplace – precise market intelligence that can be translated into action.
Products and services
Organizing a vast array of healthcare data and facts into solid, relevant metrics to help answer key questions is an enormous undertaking. IMS can apply insight and capabilities to a tremendously rich set of data assets and analytics. We are the gold standard in pharmaceutical and healthcare market intelligence, relied on by virtually all of the world’s largest pharmaceutical and biotech companies — along with government agencies, policymakers, researchers and financial analysts around the globe.
Our end-to-end solutions — integrating unparalleled information, analytics, consulting and services — play a central role in supporting high-quality, cost-effective healthcare. Our people bring the facts and figures to life, leveraging our extensive global network and expertise.
Interviews
Related
EMA Headquarters to Move to Amsterdam
The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use…
Interview: Leo De Haan – Managing Director Benelux, Aurobindo, The…
Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in…
The Netherlands: A Fertile Garden for Innovation
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by…
Forging the Future of Healthcare in the Netherlands
The Netherlands is clearly a fertile environment for its 2,200 life science and medtech companies. However, the…
Interview: Karel Fol – Country Manager Benelux, Sobi, The Netherlands
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to…
Interview: Paul Korte – General Manager, Janssen Netherlands
Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position…
Interview: Hans Hofstraat – Vice President, Philips Research, The…
In an exclusive interview, the Vice President of Philips Research explains the key to continuous evolution,…
Interview: Roland van Esch – Managing Director, Zimmer Biomet, The…
Healthcare is moving towards an increased level of personalization and active participation of the patient in the…
Interview: Hennie Henrichs – General Manager Benelux & Nordics, Teva,…
Teva Benelux and Nordics’ GM lifts the lid on how the company has grown to become the market leader in the…
Interview: Aarnoud Overkamp – Managing Director, Takeda Netherlands
Takeda’s goal is to become a trusted and reliable partner in the healthcare system by better understanding…
Interview: Lo Wuite – General Manager Managed Equipment Services Europe;…
In many aspects, 2016 truly marks the dawn of a new era for Toshiba Medical Systems. Lo Wuite (LW), General Manager…
Interview: Fred Westdijk – Vice President Life Sciences & Healthcare;…
DHL Supply Chain Benelux understands the challenges life sciences companies face and has developed solutions to…
